(Q34196973)

English

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

scientific article published on May 10, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

0 references

0 references

Nancy Fern Olivieri

2

object named as

Nancy F Olivieri

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Patricia J Giardina

3

object named as

Patricia J Giardina

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ellis J Neufeld

5

object named as

Ellis J Neufeld

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Eric Nisbet-Brown

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Romain Séchaud

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Daniele Alberti

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Robert W. Grady

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12747879

2 January 2024

Axel J. Krebs-Brown

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12747879

2 January 2024

Judith R. Anderson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12747879

2 January 2024

Kurt C. Sizer

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12747879

2 January 2024

David G. Nathan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12747879

2 January 2024

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

10 May 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12747879

2 January 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0140673603133090?httpAccept=text/xml

1 reference

10.1016/S0140-6736(03)13309-0

https://api.crossref.org/works/10.1016/S0140-6736(03)13309-0

2 January 2024

https://api.elsevier.com/content/article/PII:S0140673603133090?httpAccept=text/plain

1 reference

10.1016/S0140-6736(03)13309-0

https://api.crossref.org/works/10.1016/S0140-6736(03)13309-0

2 January 2024

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

361

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9369

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1597-1602

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Oral iron chelation therapy for thalassaemia: an uncertain scene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical management of iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The development of hydroxypyridin-4-ones as orally active iron chelators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron-chelation therapy with oral deferiprone in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety profile of the oral iron chelator deferiprone: a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver iron and fibrosis during long-term treatment with deferiprone in Swiss thalassaemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing effectiveness of deferiprone in a thalassaemia major clinical setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA genes in Macedonians and the sub-Saharan origin of the Greeks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-A, -B, -DR antigens in the Greek Cypriot population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of non-transferrin bound iron in disorders of iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913309-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary metabolic profiles in human and rat of 1,2-dimethyl- and 1,2-diethyl-substituted 3-hydroxypyridin-4-ones

12

1 reference

10.1016/S0140-6736(03)13309-0

https://api.crossref.org/works/10.1016/S0140-6736(03)13309-0

2 January 2024

The deferiprone controversy: time to move on

17

1 reference

10.1016/S0140-6736(03)13309-0

https://api.crossref.org/works/10.1016/S0140-6736(03)13309-0

2 January 2024

Identifiers

10.1016/S0140-6736(03)13309-0

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34196973&oldid=2043454084"